227 related articles for article (PubMed ID: 21951387)
1. Current evidence for a role of GLP-1 in Roux-en-Y gastric bypass-induced remission of type 2 diabetes.
Rhee NA; Vilsbøll T; Knop FK
Diabetes Obes Metab; 2012 Apr; 14(4):291-8. PubMed ID: 21951387
[TBL] [Abstract][Full Text] [Related]
2. Impact of the hepatic branch of the vagus and Roux-en-Y gastric bypass on the hypoglycemic effect and glucagon-like peptide-1 in rats with type 2 diabetes mellitus.
Qiu NC; Zhang Q; Song X; Liu ME; Li XK; Shan CX; Qiu M
J Surg Res; 2014 Sep; 191(1):123-9. PubMed ID: 24768143
[TBL] [Abstract][Full Text] [Related]
3. The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass.
Kim MK; Lee HC; Lee SH; Kwon HS; Baek KH; Kim EK; Lee KW; Song KH
Diabetes Metab Res Rev; 2012 Jul; 28(5):439-46. PubMed ID: 22407971
[TBL] [Abstract][Full Text] [Related]
4. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.
Kadera BE; Lum K; Grant J; Pryor AD; Portenier DD; DeMaria EJ
Surg Obes Relat Dis; 2009; 5(3):305-9. PubMed ID: 19460674
[TBL] [Abstract][Full Text] [Related]
5. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
[TBL] [Abstract][Full Text] [Related]
6. Neuro-modulation and bariatric surgery for type 2 diabetes mellitus.
Spector D; Shikora S
Int J Clin Pract Suppl; 2010 Feb; (166):53-8. PubMed ID: 20377665
[TBL] [Abstract][Full Text] [Related]
7. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
[TBL] [Abstract][Full Text] [Related]
8. GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects.
Jiménez A; Casamitjana R; Flores L; Delgado S; Lacy A; Vidal J
Ann Surg; 2013 May; 257(5):894-9. PubMed ID: 23579541
[TBL] [Abstract][Full Text] [Related]
9. Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
Pop LM; Mari A; Zhao TJ; Mitchell L; Burgess S; Li X; Adams-Huet B; Lingvay I
Diabetes Obes Metab; 2018 Jul; 20(7):1710-1721. PubMed ID: 29532631
[TBL] [Abstract][Full Text] [Related]
10. Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery.
Cummings DE
Int J Obes (Lond); 2009 Apr; 33 Suppl 1():S33-40. PubMed ID: 19363506
[TBL] [Abstract][Full Text] [Related]
11. Role of the incretin system in the remission of type 2 diabetes following bariatric surgery.
Mingrone G
Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):574-9. PubMed ID: 18790374
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects.
Jiménez A; Casamitjana R; Flores L; Viaplana J; Corcelles R; Lacy A; Vidal J
Ann Surg; 2012 Dec; 256(6):1023-9. PubMed ID: 22968072
[TBL] [Abstract][Full Text] [Related]
13. The role of obestatin in roux-en-Y gastric bypass-induced remission of type 2 diabetes mellitus.
Wang JL; Xu XH; Zhang XJ; Li WH
Diabetes Metab Res Rev; 2016 Sep; 32(6):470-7. PubMed ID: 26445403
[TBL] [Abstract][Full Text] [Related]
14. Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.
Carmody JS; Muñoz R; Yin H; Kaplan LM
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E855-61. PubMed ID: 27026085
[TBL] [Abstract][Full Text] [Related]
15. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass.
Chikunguwo SM; Wolfe LG; Dodson P; Meador JG; Baugh N; Clore JN; Kellum JM; Maher JW
Surg Obes Relat Dis; 2010; 6(3):254-9. PubMed ID: 20303324
[TBL] [Abstract][Full Text] [Related]
16. Gastric bypass in the pig increases GIP levels and decreases active GLP-1 levels.
Lindqvist A; Ekelund M; Pierzynowski S; Groop L; Hedenbro J; Wierup N
Peptides; 2017 Apr; 90():78-82. PubMed ID: 28242256
[TBL] [Abstract][Full Text] [Related]
17. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
Rohde U
Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
[TBL] [Abstract][Full Text] [Related]
18. Roux-en-Y gastric bypass stands the test of time: 5-year results in low body mass index (30-35 kg/m(2)) Indian patients with type 2 diabetes mellitus.
Lakdawala M; Shaikh S; Bandukwala S; Remedios C; Shah M; Bhasker AG
Surg Obes Relat Dis; 2013; 9(3):370-8. PubMed ID: 23068107
[TBL] [Abstract][Full Text] [Related]
19. Gastric bypass surgery: improving psoriasis through a GLP-1-dependent mechanism?
Faurschou A; Zachariae C; Skov L; Vilsbøll T; Knop FK
Med Hypotheses; 2011 Dec; 77(6):1098-101. PubMed ID: 21968278
[TBL] [Abstract][Full Text] [Related]
20. Is sleeve gastrectomy as effective as gastric bypass for remission of type 2 diabetes in morbidly obese patients?
de Gordejuela AG; Pujol Gebelli J; García NV; Alsina EF; Medayo LS; Masdevall Noguera C
Surg Obes Relat Dis; 2011; 7(4):506-9. PubMed ID: 21411376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
